| ATC code A: Alimentary tract and metabolism |
|---|
|
| Other ATC codes |
ATC code A14 Anabolic agents for systemic use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup A14 is part of the anatomical group A Alimentary tract and metabolism.[4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QA14.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
A14A Anabolic steroids[edit]
A14AA Androstan derivatives[edit]
- A14AA01 Androstanolone
- A14AA02 Stanozolol
- A14AA03 Metandienone
- A14AA04 Metenolone
- A14AA05 Oxymetholone
- A14AA06 Quinbolone
- A14AA07 Prasterone
- A14AA08 Oxandrolone
- A14AA09 Norethandrolone
A14AB Estren derivatives[edit]
- A14AB01 Nandrolone
- A14AB02 Ethylestrenol
- A14AB03 Oxabolone cipionate
A14B Other anabolic agents[edit]
References[edit]
- ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- ^ "ATC/DDD Index 2022: code A14". WHO Collaborating Centre for Drug Statistics Methodology.
- ^ "ATCvet Index 2022: code QA14". WHO Collaborating Centre for Drug Statistics Methodology.